Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. CytoDyn Inc (CYDY) Message Board

“Metformin with the usual liver / kidney concern

Message Board Public Reply | Private Reply | Keep | Replies (2)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 155054
(Total Views: 840)
Posted On: 11/15/2020 1:40:05 PM
Avatar
Posted By: ClosetInvestor
Re: JLang #65527
“Metformin with the usual liver / kidney concerns.”

Investors can not get over the fact that drugs have side effects. Yes, drugs have side effects but what’s important is that those side effects occur in SOME patients. Providers always consider side effects when prescribing medications, but they understand how common that side effect is and what can increase the chances of that side effect (age, comorbidities, medications, etc.). Lactic acidosis and/or hepatotoxicity occurs is less than 1% of patients, are resolved by discontinuing the medication and has not been fatal.

Let’s play a game. The information below is the side effects from a very common drug. Look at all this terrible side effects one COULD get? Stevens-Johnson syndrome and systemic lupus erythematosus? Yikes. The name of the drug is at the end.

Oral:
>10%:
-Hematologic & oncologic: Decreased hemoglobin (7% to 23%)
-Hepatic: Increased serum alanine aminotransferase (≤15%), increased serum aspartate aminotransferase (≤15%)

1% to 10%:
-Cardiovascular: Edema
-Central nervous system: Dizziness (3% to 9%), headache, nervousness
-Dermatologic: Skin rash (3% to 9%), maculopapular rash, pruritus
-Endocrine & metabolic: Fluid retention
-Gastrointestinal: Epigastric pain (3% to 9%), heartburn (3% to 9%), nausea (3% to 9%), abdominal cramps, abdominal distress, abdominal pain, bloating, constipation, decreased appetite, diarrhea, dyspepsia, flatulence, nausea and vomiting, vomiting
-Hematologic & oncologic: Anemia, prolonged bleeding time
-Hepatic: Increased liver enzymes
-Otic: Tinnitus (<3%)
-Renal: Renal function abnormality

<1%, postmarketing, and/or case reports: Abnormal dreams, abnormal hepatic function tests, acidosis, acute renal failure, agranulocytosis, alopecia, amblyopia, anaphylactoid shock, anaphylaxis, anemia, angioedema, aplastic anemia, apnea, aseptic meningitis, auditory impairment, azotemia, blurred vision, bronchospasm, cardiac arrhythmia, cardiac failure, cataract, cerebrovascular accident, change in appetite, chills, coma, confusion, conjunctivitis, cystitis, decreased creatinine clearance, decreased hematocrit, depression, diplopia, DRESS syndrome (Koca 2016; Roales-Gómez 2014), drowsiness, duodenal ulcer, emotional lability, eosinophilia, epistaxis, eructation, erythema multiforme, exfoliative dermatitis, fever, gastric ulcer, gastritis, gastrointestinal hemorrhage, gastrointestinal perforation, gastrointestinal ulcer, gingival ulceration, glomerulonephritis, gynecomastia, hallucination, hearing loss, heavy menstrual bleeding, hematuria, hemolytic anemia, hemorrhage, Henoch-Schonlein purpura, hepatic failure, hepatic necrosis, hepatitis, hepatorenal syndrome, hepatotoxicity drowsiness, duodenal ulcer, emotional lability, eosinophilia, epistaxis, eructation, erythema multiforme, exfoliative dermatitis, fever, gastric ulcer, gastritis, gastrointestinal hemorrhage, gastrointestinal perforation, gastrointestinal ulcer, gingival ulceration, glomerulonephritis, gynecomastia, hallucination, hearing loss, heavy menstrual bleeding, hematuria, hemolytic anemia, hemorrhage, Henoch-Schonlein purpura, hepatic failure, hepatic necrosis, hepatitis, hepatorenal syndrome, hepatotoxicity (idiosyncratic) (Chalasani 2014), hyperglycemia, hypoglycemia, hypotension, increased serum creatinine, insomnia, jaundice, lymphadenopathy, melena, myocardial infarction, neutropenia, nonthrombocytopenic purpura, occult blood in stools, optic neuritis, palpitations, pancreatitis, pancytopenia, paresthesia, pneumonia, polyuria, pseudotumor cerebri, renal papillary necrosis, renal tubular necrosis, respiratory depression, rhinitis, scotoma, seizure, serum sickness, sinus bradycardia, sinus tachycardia, skin photosensitivity, Stevens-Johnson syndrome, systemic lupus erythematosus, thrombocytopenia, thrombosis, toxic epidermal necrolysis, urticaria, vasculitis, vesiculobullous dermatitis, vision color changes, vision loss, xerophthalmia, xerostomia

Drug: Ibuprofen


(5)
(0)




CytoDyn Inc (CYDY) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us